Please login or register first to view this content.
Cardiovascular Disease Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
HF Patient Develops Psychiatric Symptoms Following Sacubitril/Valsartan Dose Escalation
Pharmacy Closures and Medication Adherence: What’s the Link?
Evidence Supporting Niacin Use for Cardiovascular Disease Prevention Evaluated
Over Half of Patients Have Suboptimal Response to Statins
Normalizing BP in Elderly With Hypertension May Up Mortality
New-Onset Non-Ischemic Cardiomyopathy Linked to Gabapentin Use
Is There Evidence to Support Kombucha Health Claims in Humans?
More Secondary Prevention Meds May Reduce Deaths After AMI
Dietary Supplement Use Not Linked to Mortality Benefits
Yosprala Available Again for Secondary Prevention of CVD With Gastroprotection
Novel Reversal Agent for Ticagrelor Gets FDA’s Breakthrough Tx Designation
Esuberaprost Development Ends After PAH Trial Fails to Meet Primary Endpoint
Ready-to-Administer Adenosine Simplist Syringes Now Available
Here’s a List of Nitrosamine-Free ARB Medications, According to the FDA
New FDA-Approved Treatment Significantly Reduces Infarct Size in MI Patients
Tudorza Pressair Labeling Updated With Data Related to COPD Patients With Cardiovascular Comorbidity
FDA Approves First Generic Versions of Letairis, Adds New REMS Program
Vascepa sNDA Seeking Expanded Indication to Reduce Major CV Events
